What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Cancer, Internal medicine, Cancer research, Oncology and Pathology.
His Cancer research is multidisciplinary, relying on both Surgical oncology and microRNA.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery.
His Cancer research research includes elements of Epithelial–mesenchymal transition, Downregulation and upregulation, Gene expression profiling, Immunology and Colorectal cancer.
Yuichiro Doki focuses mostly in the field of Oncology, narrowing it down to topics relating to Gemcitabine and, in certain cases, Pancreatic cancer.
His Pathology research includes themes of Stomach cancer, Cadherin, Oncogene and Gastrointestinal cancer.
His most cited work include:
- Reprogramming of mouse and human cells to pluripotency using mature microRNAs. (617 citations)
- CD13 is a therapeutic target in human liver cancer stem cells (418 citations)
- Expression of Immunoreactive E-Cadherin Adhesion Molecules in Human Cancers (338 citations)
What are the main themes of his work throughout his whole career to date?
Yuichiro Doki mainly focuses on Internal medicine, Surgery, Cancer, Cancer research and Oncology.
Internal medicine connects with themes related to Gastroenterology in his study.
His work carried out in the field of Surgery brings together such families of science as Gastrectomy and General surgery.
His Cancer research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Pathology.
Yuichiro Doki combines subjects such as Cell growth, Cancer cell, Cancer stem cell and Apoptosis, Cell cycle with his study of Cancer research.
His biological study spans a wide range of topics, including Survival rate, Carcinoma and Cisplatin.
He most often published in these fields:
- Internal medicine (34.44%)
- Surgery (29.26%)
- Cancer (27.39%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (34.44%)
- Cancer (27.39%)
- Surgery (29.26%)
In recent papers he was focusing on the following fields of study:
Yuichiro Doki spends much of his time researching Internal medicine, Cancer, Surgery, Cancer research and Gastroenterology.
His Internal medicine study frequently links to adjacent areas such as Oncology.
The study incorporates disciplines such as Immunohistochemistry, Incidence and Disease in addition to Cancer.
He is involved in the study of Surgery that focuses on Laparoscopic surgery in particular.
In his study, Gene knockdown and Stage is inextricably linked to Colorectal cancer, which falls within the broad field of Cancer research.
The various areas that Yuichiro Doki examines in his Gastroenterology study include Multivariate analysis, Adverse effect, Retrospective cohort study, Hazard ratio and Abdominal surgery.
Between 2018 and 2021, his most popular works were:
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial (141 citations)
- Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. (124 citations)
- Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 (101 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Cancer, Internal medicine, Cancer research, Esophageal cancer and Gastroenterology.
His research integrates issues of Immunohistochemistry and Multivariate analysis in his study of Cancer.
His Internal medicine study frequently involves adjacent topics like Oncology.
His studies deal with areas such as Cell culture, Pancreatic cancer, Cancer cell, Cancer stem cell and Colorectal cancer as well as Cancer research.
His Colorectal cancer study combines topics in areas such as Surgery and Gene knockdown.
His Esophageal cancer study integrates concerns from other disciplines, such as Esophagus, Surgical oncology, Chemotherapy and Cardiothoracic surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
